Insmed To Present at the BofA Securities 2025 Health Care Conference
Get Alerts INSM Hot Sheet
Join SI Premium – FREE
This event will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in
Headquartered in
Contact:
Investors:
Vice President, Investor Relations
(646) 812-4030
[email protected]
Media:
Vice President, Corporate Communications
(862) 842-6819
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-bofa-securities-2025-health-care-conference-302440428.html
SOURCE Insmed Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helcim Raises $53 Million Series C as Banks Exit Small Business Payments
- Ceretone and Easter Seals Greater Houston Bring Hearing Technology to Local Seniors Through Community Initiative
- Viettel Brings Two Decades of International Telecom Experience to the Dominican Republic
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share